Literature DB >> 7959569

Role of free radicals in liver diseases and hepatic fibrosis.

R S Britton1, B R Bacon.   

Abstract

An increased production of free radicals in the liver has been implicated in a variety of liver diseases. Free radicals can damage cellular macromolecules and, therefore, may participate in hepatocellular injury when produced in excess. Strong evidence exists for hepatic free radical production in animal models of iron and copper overload, ethanol consumption, and ischemia-reperfusion. Although less is known about the situation in humans with liver diseases, the available evidence is consistent with the findings in animal experiments. Treatments that reduce free radical production and/or levels have protective effects in hepatic ischemia-reperfusion. Free radical-initiated lipid peroxidation may play a role in hepatic fibrogenesis, perhaps through an effect of aldehydic peroxidation products on Kupffer cells and lipocytes. This hypothesis is supported by the observation that dietary supplementation with vitamin E has a protective effect on carbon tetrachloride-induced hepatic fibrosis. While cellular damage in human liver diseases is probably multifactorial, free radicals may play important roles in initiating and/or perpetuating this damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959569

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  23 in total

1.  Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring.

Authors:  F Imbert-Bismut; F Charlotte; B Turlin; L Khalil; A Piton; P Brissot; Y Le Charpentier; J Delattre; P Opolon; Y Deugnier; T Poynard
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

2.  Oxidative stress profile in the post-operative patients with biliary atresia.

Authors:  Takahiro Asakawa; Yoshiaki Tanaka; Kimio Asagiri; Hidefumi Kobayashi; Ken Tanikawa; Minoru Yagi
Journal:  Pediatr Surg Int       Date:  2008-11-14       Impact factor: 1.827

3.  Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression.

Authors:  Sang Hwa Lee; Sung-Im Do; Hyun-Soo Kim
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  Protective influence of vitamin E on the antioxidant defence system in the whole blood and liver of normal and alloxan-induced diabetic rats.

Authors:  J O Olanlokun
Journal:  Indian J Clin Biochem       Date:  2008-03-06

5.  The herbal medicines Inchinkoto and Saireito improved hepatic fibrosis via aquaporin 9 in the liver of a rat bile duct ligation model.

Authors:  Naoki Hashizume; Ryusuke Shin; Jun Akiba; Naoki Sotogaku; Kimio Asagiri; Shigeki Hikida; Suguru Fukahori; Shinji Ishii; Nobuyuki Saikusa; Yoshinori Koga; Hideaki Egami; Yoshiaki Tanaka; Akinori Nishi; Minoru Yagi
Journal:  Pediatr Surg Int       Date:  2021-03-12       Impact factor: 1.827

6.  In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.

Authors:  V Paradis; P Mathurin; M Kollinger; F Imbert-Bismut; F Charlotte; A Piton; P Opolon; A Holstege; T Poynard; P Bedossa
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

7.  Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats.

Authors:  G Schimpl; P Pesendorfer; G Steinwender; G Feierl; M Ratschek; M E Höllwarth
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

8.  Antioxidant potential of rat liver in experimental infection with Fasciola hepatica.

Authors:  L Kolodziejczyk; E Siemieniuk; E Skrzydlewska
Journal:  Parasitol Res       Date:  2005-06-01       Impact factor: 2.289

9.  Alcohol-induced generation of lipid peroxidation products in humans.

Authors:  E A Meagher; O P Barry; A Burke; M R Lucey; J A Lawson; J Rokach; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

10.  HNE interacts directly with JNK isoforms in human hepatic stellate cells.

Authors:  M Parola; G Robino; F Marra; M Pinzani; G Bellomo; G Leonarduzzi; P Chiarugi; S Camandola; G Poli; G Waeg; P Gentilini; M U Dianzani
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.